Harvard Bioscience, Inc.
Harvard Bioscience, Inc. (HBIO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HBIO · as of Jun 9, 2026
Key Statistics
Explore Harvard Bioscience, Inc. Data
hbio stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 5 · Buy rate: 80.0%
The HBIO analyst consensus is Buy, based on ratings from 5 Wall Street analysts over the past 3 months. The average 12-month price target is $6.00, representing -0.17% downside from the current price of $6.01.
Competitors & Peers
hbio competitorsHBIO
CLGN
COSM
FEMY
NCNA
NXGLStock Performance
Full HistoryAbout Harvard Bioscience, Inc.
Harvard Bioscience, Inc. (HBIO) is a global provider of cutting-edge technologies, products, and services crucial for fundamental scientific investigation, drug discovery, and preclinical testing. Ser…
what is harvard bioscience, inc. · hbio stock overview · harvard bioscience, inc. company profile · who is harvard bioscience, inc. ceo · hbio NASDAQ · harvard bioscience, inc. headquarters · harvard bioscience, inc. business segments
About Stock Overview & Key Data
Harvard Bioscience, Inc. (HBIO) is a Healthcare company in the Medical - Instruments & Supplies industry, listed on NASDAQ since Mar 19, 2001. As of the latest trading session, HBIO stock price is $6.01, with a market capitalization of $27.1M. The stock has returned +7.71% over the past 12 months and -10.16% year-to-date.
According to 5 Wall Street analysts, the consensus rating for Harvard Bioscience, Inc. stock is Buy, with an average 12-month price target of $6.00. In fiscal year 2025, Harvard Bioscience, Inc. reported revenue of $86.5M and net income of -$56.7M. For detailed data — including Harvard Bioscience, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Harvard Bioscience, Inc. (HBIO) stock price is $6.01. The stock is traded on NASDAQ under the ticker symbol HBIO. The 52-week range is $3.80 – $9.40.